Immutep Limited (IMMP) Social Stream



Immutep Limited (IMMP): $3.23

0.13 (+4.19%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add IMMP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#218 of 360

in industry

IMMUTEP LTD (IMMP) Price Targets From Analysts

Use the tables below to see what analysts covering IMMUTEP LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-03 1 $8.3 $8 $8.15 $2.46 231.3%
2022-06-03 2 $8.3 $8 $8.15 $2.46 231.3%
2023-02-28 3 $8.3 $8 $8.15 $2.46 231.3%
2023-06-02 3 $10 $8.3 $9.15 $2.46 271.95%
2023-08-02 3 $10 $7 $8.433 $2.46 242.8%
2023-10-05 4 $10 $7 $8.433 $2.46 242.8%

Over the past 31 weeks, IMMP's average upside potential has been 329.39%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-28 3 8.3 8.0 8.150 1.63 400%
2023-05-18 3 10.0 8.3 9.150 2.43 276.54%
2023-06-02 3 10.0 8.3 9.150 2.07 342.03%
2023-08-02 3 10.0 7.0 8.433 2.13 295.92%
2023-08-02 4 10.0 7.0 8.433 2.13 295.92%

IMMP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


IMMP's average broker recommendation rating improved by 0 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMMP as an investment opportunity.

  • In terms of how IMMUTEP LTD fares relative to all US stocks, note that its number of analysts covering the stock is greater than 38.32% of that group.
  • In the context of all US stocks, IMMUTEP LTD's average analyst price target is greater than 52.37% of them.
  • In the context of Pharmaceutical Products stocks, IMMUTEP LTD's variance in analysts' estimates is lower than 38.25% of them.
  • In terms of how IMMUTEP LTD fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 434.94% of that group.

Stocks similar to IMMUTEP LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PRQR, AFMD, and KALV.

Is IMMP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!